TD Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-12,685
| Closed | -$863K | – | 1378 |
|
|
2017
Q4 | $863K | Sell |
12,685
-11,800
| -48% | -$803K | ﹤0.01% | 1084 |
|
|
2017
Q3 | $2.02M | Sell |
24,485
-18,367
| -43% | -$1.51M | ﹤0.01% | 862 |
|
|
2017
Q2 | $4.01M | Buy |
42,852
+33,326
| +350% | +$3.12M | 0.01% | 721 |
|
|
2017
Q1 | $607K | Sell |
9,526
-7,700
| -45% | -$491K | ﹤0.01% | 1168 |
|
|
2016
Q4 | $765K | Sell |
17,226
-13,474
| -44% | -$598K | ﹤0.01% | 1078 |
|
|
2016
Q3 | $1.11M | Sell |
30,700
-5,400
| -15% | -$195K | ﹤0.01% | 986 |
|
|
2016
Q2 | $495K | Sell |
36,100
-500
| -1% | -$6.86K | ﹤0.01% | 1122 |
|
|
2016
Q1 | $703K | Sell |
36,600
-1,200
| -3% | -$23K | ﹤0.01% | 1037 |
|
|
2015
Q4 | $1.32M | Sell |
37,800
-9,000
| -19% | -$315K | ﹤0.01% | 898 |
|
|
2015
Q3 | $4.3M | Sell |
46,800
-1,000
| -2% | -$92K | 0.01% | 675 |
|
|
2015
Q2 | $4.2M | Sell |
47,800
-6,200
| -11% | -$545K | 0.01% | 728 |
|
|
2015
Q1 | $4.01M | Buy |
54,000
+4,200
| +8% | +$312K | 0.01% | 710 |
|
|
2014
Q4 | $2.79M | Buy |
49,800
+25,100
| +102% | +$1.41M | ﹤0.01% | 793 |
|
|
2014
Q3 | $1.12M | Sell |
24,700
-1,000
| -4% | -$45.3K | ﹤0.01% | 890 |
|
|
2014
Q2 | $1.06M | Buy |
25,700
+8,100
| +46% | +$335K | ﹤0.01% | 898 |
|
|
2014
Q1 | $1.22M | Buy |
17,600
+900
| +5% | +$62.3K | ﹤0.01% | 880 |
|
|
2013
Q4 | $1.01M | Buy |
16,700
+6,500
| +64% | +$392K | ﹤0.01% | 885 |
|
|
2013
Q3 | $620K | Hold |
10,200
| – | – | ﹤0.01% | 935 |
|
|
2013
Q2 | $683K | Buy |
+10,200
| New | +$683K | ﹤0.01% | 888 |
|